Startup funding grows more concentrated, Chainfir Capital says

PUBT · 2d ago
Startup funding grows more concentrated, Chainfir Capital says
  • Chainfir Capital's analysis points to increasing concentration in startup funding rather than a broad recovery in capital availability.
  • Isomorphic Labs' $5 billion Series C on November 17 captured roughly 78% of $6.4 billion raised by 13 companies.
  • Bloomberg reported a valuation of about $50 billion for Isomorphic, whose drug programs remain preclinical.
  • The analysis sees less competition for other investments, creating opportunities for early-stage managers in Hong Kong, Singapore and New Zealand.
  • The firm's strategy targets profitable businesses with at least eight quarters of positive operating contribution, using its own capital for 90% of investments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chainfir Capital published the original content used to generate this news brief on November 18, 2026, and is solely responsible for the information contained therein.